These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21701006)

  • 1. Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.
    Yaghmai V; Miller FH; Rezai P; Benson AB; Salem R
    AJR Am J Roentgenol; 2011 Jul; 197(1):18-27. PubMed ID: 21701006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to treatment series: part 1 and introduction, measuring tumor response--challenges in the era of molecular medicine.
    Sullivan DC; Gatsonis C
    AJR Am J Roentgenol; 2011 Jul; 197(1):15-7. PubMed ID: 21701005
    [No Abstract]   [Full Text] [Related]  

  • 3. Response assessment in oncology: limitations of anatomic response criteria in the era of tailored treatments.
    Carnaghi C; Sclafani F; Basilico V; Doherty M
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):589-602. PubMed ID: 22231580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of liver tumor response to therapy: role of quantitative imaging.
    Gonzalez-Guindalini FD; Botelho MP; Harmath CB; Sandrasegaran K; Miller FH; Salem R; Yaghmai V
    Radiographics; 2013 Oct; 33(6):1781-800. PubMed ID: 24108562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.
    Herrmann K; Benz MR; Krause BJ; Pomykala KL; Buck AK; Czernin J
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):620-32. PubMed ID: 22231582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
    Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
    Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT and MRI in monitoring response: state-of-the-art and future developments.
    D'Ippolito G; Torres LR; Saito Filho CF; Ferreira RM
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):603-19. PubMed ID: 22231581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)].
    Kusaba H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.
    Egger ME; Cannon RM; Metzger TL; Nowacki M; Kelly L; Tatum C; Scoggins CR; Callender GG; McMasters KM; Martin RC
    J Am Coll Surg; 2013 Apr; 216(4):845-56; discussion 856-7. PubMed ID: 23415549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiological evaluation of tumor response in oncological studies (tumor response evaluation)].
    Gebauer B; Bohnsack O; Riess H
    Rofo; 2011 Aug; 183(8):695-703. PubMed ID: 21391174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of tumour response to cancer treatment: morphologic imaging role].
    Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
    Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer treatment response evaluation based on imaging modalities, such as computed tomography, magnetic resonance imaging and FDG-PET].
    Endo M; Aramaki T; Moriguchi M; Sawada A; Asakura K; Bekku E
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):294-8. PubMed ID: 23507590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of molecular techniques for imaging and treatment of tumors.
    Haberkorn U; Markert A; Eisenhut M; Mier W; Altmann A
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):655-70. PubMed ID: 22231585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing tumor response to therapy.
    Weber WA
    J Nucl Med; 2009 May; 50 Suppl 1():1S-10S. PubMed ID: 19380403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice.
    Alves F; Dullin C; Napp J; Missbach-Guentner J; Jannasch K; Mathejczyk J; Pardo LA; Stühmer W; Tietze LF
    Eur J Radiol; 2009 May; 70(2):286-93. PubMed ID: 19285818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.